TECH Share Price

Open 116.25 Change Price %
High 117.80 1 Day 1.20 1.03
Low 113.91 1 Week 5.87 5.26
Close 117.50 1 Month 6.44 5.80
Volume 305741 1 Year 6.04 5.42
52 Week High 117.80
52 Week Low 95.68
TECH Important Levels
Resistance 2 121.11
Resistance 1 119.62
Pivot 116.40
Support 1 115.38
Support 2 113.89
NASDAQ USA Most Active Stocks
YHOO 52.58 0.00%
YHOO 52.58 0.00%
YHOO 52.58 0.00%
DCTH 0.16 -33.33%
FTR 1.22 8.93%
FTR 1.22 8.93%
ASTI 0.00 0.00%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
More..
NASDAQ USA Top Gainers Stocks
OPXAW 0.12 200.00%
AVEO 1.25 71.23%
LOCM 0.09 50.00%
MYRX 0.09 50.00%
SNCR 16.24 33.33%
QUIK 1.60 31.15%
WRES 0.09 28.57%
IIN 8.35 27.48%
IIN 8.35 27.48%
IIN 8.35 27.48%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
TOPS 0.80 -66.67%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
SPIR 0.01 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
More..

Techne Corporation (NASDAQ: TECH)

TECH Technical Analysis 5
As on 23rd Jun 2017 TECH Share Price closed @ 117.50 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 106.32 & Strong Buy for SHORT-TERM with Stoploss of 109.05 we also expect STOCK to react on Following IMPORTANT LEVELS.
TECH Target for June
1st Target up-side 115.89
2nd Target up-side 118.56
3rd Target up-side 121.23
1st Target down-side 108.27
2nd Target down-side 105.6
3rd Target down-side 102.93
TECH Other Details
Segment EQ
Market Capital 2603798528.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.techne-corp.com
TECH Address
TECH
614 McKinley Place North East
Minneapolis, MN 55413-2610
United States
Phone: 612-379-8854
Fax: 612-379-6580
Interactive Technical Analysis Chart Techne Corporation ( TECH NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Techne Corporation
TECH Business Profile
TECHNE Corporation is engaged in the development, manufacture and sale of biotechnology products and hematology calibrators and controls. These activities are conducted through its wholly owned subsidiaries, Research and Diagnostic Systems, Inc. (R&D Systems), Boston Biochem, Inc. (Boston Biochem), and BiosPacific, Inc. (BiosPacific). The Company operates in two segments: biotechnology and hematology. The Company's biotechnology reporting segment develops, manufactures and sells biotechnology research and diagnostic products world-wide. The Company's hematology reporting segment, which consists of R&D Systems' Hematology Division, develops and manufactures hematology controls and calibrators for sale worldwide. In July 2013, the Company announced that it has completed the acquisition of Bionostics Holdings Limited and its operating subsidiary Bionostics, Inc. (Bionostics).